Podcasts about post covid

SummaryIn this episode of the Restaurant Owners Uncorked podcast, Will interviews Jon Darby, owner of Darby's American Cantina. They discuss John's journey into the restaurant industry, the challenges of managing a restaurant, the impact of minimum wage laws, and the evolving trends in alcohol consumption. Jon shares insights on the importance of community support among restaurant owners and the realities of running a restaurant in today's economy, especially post-COVID. The conversation also touches on family dynamics within the business and the technological advancements that have changed the industry.Takeaways Jon started in hospitality while working at Capitol Records. He transitioned to running a restaurant after helping his mother. Leases are crucial; longer terms provide stability. The restaurant industry requires constant adaptation to trends. Minimum wage increases impact pricing and profitability. Post-COVID challenges have reshaped the restaurant landscape. Alcohol sales trends are shifting towards higher-end spirits. Community support among restaurant owners is vital. Technology has transformed scheduling and operations in restaurants. Family involvement adds a personal touch to the business.

00:03:58:22 - 00:09:55:09Rising incidents of truck crashes (e.g., Austin I-35, Thomasville, Alabama) linked to unqualified drivers, often immigrants on work visas.Ghost carriers operate with fake addresses (e.g., pizza joint in Illinois, apartment complex in Dallas), enabling fraud and theft.Lack of proper training and oversight, with companies prioritizing cost over safety, leading to loss of lives and national security concerns.00:21:17:19 - 00:24:09:18Nissan plans to cut 20,000 jobs (15% of workforce) by 2027, including 9,000 previously announced, and scale back production.Speculation: Cuts driven by uncertainty in North American market (38% of sales, US 27%), fearing economic collapse.Regulatory pressures (e.g., EPA standards, electric vehicles) also impact car industry.00:31:26:05 - 00:36:12:20China benefits from combat testing in India-Pakistan conflict; military-industrial complex (e.g., Raytheon, Lockheed Martin) profits from wars.US diplomacy (Trump, Vance, Rubio) mediated a ceasefire after four days of nuclear-armed conflict, highlighting neutral mediation success.Neither side uses US weapons, reducing American incentive to prolong conflict.00:41:24:03 - 00:47:19:25In the 1970s, psych meds were status symbols for the wealthy; now mainstream, fueling a massive industry.Mental health issues (e.g., depression, transgender identity) are used as social hierarchy markers, elevating perceived victims.Overuse of meds (e.g., SSRIs) linked to dangerous side effects, including violent behavior, with therapy culture promoting dependency.00:59:21:10 - 01:00:46:2024-hour news cycle promotes constant fear to control populations, making people more compliant and willing to relinquish liberties.Despite statistical safety, media amplifies threats, fostering anxiety.01:09:59:09 - 01:18:23:25Trump's “Generation Gold Standard” aims for a universal flu vaccine using outdated whole killed virus technology, costing $500 million.Contradicts anti-vaccine rhetoric (e.g., RFK Jr.'s stance), raising concerns about corporate influence and potential harm.Critique of vaccine industry: excessive childhood vaccines (up to 76), harmful side effects, and systemic pressure on doctors to comply.01:29:39:03 - 01:35:47:13Pew Research shows Gen Z men attending religious services more than millennials/Gen X, closing gender gap as young women leave churches.Post-Covid isolation drives youth to seek community and meaning in faith, countering atheism's cultural decline.Focus on eternal significance of faith over political impact.01:42:00:29 - 01:43:25:00Man exonerated by DNA evidence after nearly four decades, despite proper legal procedures.Emphasizes need for due process to prevent such errors, as abandoning it risks widespread injustice.01:49:13:12 - 01:54:23:11Trump grants refugee status to 60 white South African farmers fleeing state-sanctioned persecution, criticized as racially biased.Argues for prioritizing refugees from cultures aligning with American values, citing South Africans' work ethic and liberty focus.Contrasts with open-border policies, highlighting selective immigration's role in preserving national identity.02:05:31:08 - 02:15:57:16Government funding for “school choice” (e.g., $5,000-$7,000 per student in Tennessee, Idaho, Wyoming) comes with strings, pushing state-approved curricula and control.UNESCO promotes universal government funding to integrate private and homeschooling into public systems, per Alex Newman.Tennessee's failed “free act” shows resistance to homeschool autonomy; Texas Homeschool Coalition criticized for supporting funding.02:16:23:28 - 02:19:36:02Passed April 10, 2025, requiring autopsies to document psychotropic drug use (e.g., SSRIs) in mass shooters, spurred by Nashville school shooting.Aims to study drug interactions and disclose findings publicly, addressing links between SSRIs and violent behavior.Highlights exacerbation of mental health issues by pharmaceuticals, as seen in the shooter's worsening condition.02:20:04:24 - 02:47:31:19“Cold Case Christianity” graphic novel, co-authored with son, follows detectives chasing a serial killer, subtly exploring human value from a Christian perspective.Challenges secular views equating humans with animals, emphasizing humans as God's image-bearers with inherent dignity.Designed as a gateway for non-Christians, includes QR code for resurrection case booklet and resources at coldcasechristianity.com.Follow the show on Kick and watch live every weekday 9:00am EST – 12:00pm EST https://kick.com/davidknightshow Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silver For 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHT Find out more about the show and where you can watch it at TheDavidKnightShow.comIf you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-david-knight-show--2653468/support.

00:03:58:22 - 00:09:55:09Rising incidents of truck crashes (e.g., Austin I-35, Thomasville, Alabama) linked to unqualified drivers, often immigrants on work visas.Ghost carriers operate with fake addresses (e.g., pizza joint in Illinois, apartment complex in Dallas), enabling fraud and theft.Lack of proper training and oversight, with companies prioritizing cost over safety, leading to loss of lives and national security concerns.00:21:17:19 - 00:24:09:18Nissan plans to cut 20,000 jobs (15% of workforce) by 2027, including 9,000 previously announced, and scale back production.Speculation: Cuts driven by uncertainty in North American market (38% of sales, US 27%), fearing economic collapse.Regulatory pressures (e.g., EPA standards, electric vehicles) also impact car industry.00:31:26:05 - 00:36:12:20China benefits from combat testing in India-Pakistan conflict; military-industrial complex (e.g., Raytheon, Lockheed Martin) profits from wars.US diplomacy (Trump, Vance, Rubio) mediated a ceasefire after four days of nuclear-armed conflict, highlighting neutral mediation success.Neither side uses US weapons, reducing American incentive to prolong conflict.00:41:24:03 - 00:47:19:25In the 1970s, psych meds were status symbols for the wealthy; now mainstream, fueling a massive industry.Mental health issues (e.g., depression, transgender identity) are used as social hierarchy markers, elevating perceived victims.Overuse of meds (e.g., SSRIs) linked to dangerous side effects, including violent behavior, with therapy culture promoting dependency.00:59:21:10 - 01:00:46:2024-hour news cycle promotes constant fear to control populations, making people more compliant and willing to relinquish liberties.Despite statistical safety, media amplifies threats, fostering anxiety.01:09:59:09 - 01:18:23:25Trump's “Generation Gold Standard” aims for a universal flu vaccine using outdated whole killed virus technology, costing $500 million.Contradicts anti-vaccine rhetoric (e.g., RFK Jr.'s stance), raising concerns about corporate influence and potential harm.Critique of vaccine industry: excessive childhood vaccines (up to 76), harmful side effects, and systemic pressure on doctors to comply.01:29:39:03 - 01:35:47:13Pew Research shows Gen Z men attending religious services more than millennials/Gen X, closing gender gap as young women leave churches.Post-Covid isolation drives youth to seek community and meaning in faith, countering atheism's cultural decline.Focus on eternal significance of faith over political impact.01:42:00:29 - 01:43:25:00Man exonerated by DNA evidence after nearly four decades, despite proper legal procedures.Emphasizes need for due process to prevent such errors, as abandoning it risks widespread injustice.01:49:13:12 - 01:54:23:11Trump grants refugee status to 60 white South African farmers fleeing state-sanctioned persecution, criticized as racially biased.Argues for prioritizing refugees from cultures aligning with American values, citing South Africans' work ethic and liberty focus.Contrasts with open-border policies, highlighting selective immigration's role in preserving national identity.02:05:31:08 - 02:15:57:16Government funding for “school choice” (e.g., $5,000-$7,000 per student in Tennessee, Idaho, Wyoming) comes with strings, pushing state-approved curricula and control.UNESCO promotes universal government funding to integrate private and homeschooling into public systems, per Alex Newman.Tennessee's failed “free act” shows resistance to homeschool autonomy; Texas Homeschool Coalition criticized for supporting funding.02:16:23:28 - 02:19:36:02Passed April 10, 2025, requiring autopsies to document psychotropic drug use (e.g., SSRIs) in mass shooters, spurred by Nashville school shooting.Aims to study drug interactions and disclose findings publicly, addressing links between SSRIs and violent behavior.Highlights exacerbation of mental health issues by pharmaceuticals, as seen in the shooter's worsening condition.02:20:04:24 - 02:47:31:19“Cold Case Christianity” graphic novel, co-authored with son, follows detectives chasing a serial killer, subtly exploring human value from a Christian perspective.Challenges secular views equating humans with animals, emphasizing humans as God's image-bearers with inherent dignity.Designed as a gateway for non-Christians, includes QR code for resurrection case booklet and resources at coldcasechristianity.com.Follow the show on Kick and watch live every weekday 9:00am EST – 12:00pm EST https://kick.com/davidknightshow Money should have intrinsic value AND transactional privacy: Go to https://davidknight.gold/ for great deals on physical gold/silver For 10% off Gerald Celente's prescient Trends Journal, go to https://trendsjournal.com/ and enter the code KNIGHT Find out more about the show and where you can watch it at TheDavidKnightShow.comIf you would like to support the show and our family please consider subscribing monthly here: SubscribeStar https://www.subscribestar.com/the-david-knight-showOr you can send a donation throughMail: David Knight POB 994 Kodak, TN 37764Zelle: @DavidKnightShow@protonmail.comCash App at: $davidknightshowBTC to: bc1qkuec29hkuye4xse9unh7nptvu3y9qmv24vanh7Become a supporter of this podcast: https://www.spreaker.com/podcast/the-real-david-knight-show--5282736/support.

Etwa 10 % aller COVID-19-Erkrankten sind von Post-Covid betroffen - das entspricht einer Zahl von etwa einer halben Million Menschen in Deutschland.In dieser Folge geht Dr. Anne Fleck auf spezifische Symptome wie Geruchs- und Geschmacksverlust sowie Atembeschwerden ein, die viele Betroffene nach einer COVID-19-Infektion erleben. Die Episode beleuchtet die Wichtigkeit präventiver Gesundheitsmaßnahmen und moderner Lebensstilmedizin, um Krankheiten vorzubeugen und die Gesundheit zu fördern. +++Alle Rabattcodes und Infos zu unseren Werbepartnern findet ihr hier: https://linktr.ee/gesundheitundernaehrung+++

Dr. Jeremy Silver, MD, Medical Director of Emergency Medicine at Northwestern Medicine Kishwaukee Hospital, joins Elton Jim Turano (in for Dean Richards) for this week's health update. This week, Dr. Silver reflects on the development of the COVID-19 vaccine and where things stand today.

Any natural helpers for Bi-polar? | Is Muscle testing or kinesiology demonic? | Post Covid side effects for lots of people. | What can we do? | Help for 40s hormones and sleep! | What kind of magnesium is best? | Favorite methylated Bs and omegas brand? | How can I get off my acid reducer? | What help is there for POTS? | We have mold in our rental house. Does it really matter? and more!Prime Sponsor: No matter where you live, visit the Functional Medical Institute online today to connect with Drs Mark and Michele Sherwood. Go to homeschoolhealth.com to get connected and see some of my favorites items. Use coupon code HEIDI for 20% off!Give Send Go | givesendgo.comRVL Curriculum| rvlcurriculum.com/hsjShow mentions: heidistjohn.com/mentionsWebsite | heidistjohn.comSupport the show! | donorbox.org/donation-827Rumble | rumble.com/user/HeidiStJohnYoutube | youtube.com/@HeidiStJohnPodcastInstagram | @heidistjohnFacebook | Heidi St. JohnX | @heidistjohnFaith That Speaks Online CommunitySubmit your questions for Mailbox Mondayheidistjohn.net/mailboxmonday

On this Talking Real Money episode, Don and Tom tag-team one of the biggest financial myths around: your house as a retirement plan. With over $35 trillion locked in U.S. home equity, they challenge the idea that owning a home equals wealth. From the emotional pull of mortgage payoffs to the liquidity traps of reverse mortgages and HELOCs, the duo breaks down the risks, rewards, and real returns of homeownership. Then it's on to listener questions about IRAs, 401(k)s, rollovers, and... fiber (yes, the breakfast and internet kind). And they end with a little brag—because 154,000 monthly listeners can't be wrong. 0:04 $35 trillion tied up in homes—does that make us rich or just house-poor?1:20 Post-COVID home equity boom: 80% growth, but at what cost?2:53 Renting vs. buying: the case for liquidity over bricks3:44 Property tax pain for retirees and why Florida isn't so tax-free after all4:21 Mortgage payoff: emotional win, financial mistake?5:48 Why home equity shouldn't be your retirement income plan6:37 Housing's historic returns: barely 3% pre-inflation7:54 Forced savings illusion and the real cost of home improvements8:45 If you'd invested instead of buying… you'd have more9:35 Reverse mortgages, HELOCs, and why it's harder to get cash out10:19 Home equity lines now ~8%—not cheap or easy to get12:30 Big picture: don't include home equity in your retirement spending plan14:05 Florida vs. California: which really costs more to live in?16:38 Insurance, taxes, and Florida's fraud problem18:50 Listener Q: Can you do both an IRA and a 401(k) in the same year? (Yes.)20:40 IRA vs. 401(k): pros, cons, and personal strategy22:53 Listener Q: Should we roll an old 403(b) to a Roth IRA?23:44 Talking Real Money's audience numbers: brag-worthy and booming25:19 Retirement prep tip: match income to lifestyle before you retire Learn more about your ad choices. Visit megaphone.fm/adchoices

The central banks are hoarding this asset while they wait for Trump's next move! In the meantime, Warren Buffett's announced his official retirement and his handoff of leadership to Greg Abel. We talk Buffett's post-2000 investment choices, the reasons he may have avoided buying Microsoft despite his close friendship with Bill Gates, and the challenges of managing massive capital. The hosts also touch on Buffett's preference for capital-efficient, moat-heavy businesses and his indirect exposure to Microsoft through index holdings. We also discuss recent economic news, negative GDP print driven by rising inventories and reduced government spending. We discuss...  Warren Buffett officially announced his retirement, passing leadership to Greg Abel. Buffett's consistent outperformance over decades, despite criticisms of his recent picks. Buffett's size as an investor was cited as a limitation, forcing him to seek only very large investments. The recent negative GDP print, noting concerns around economic slowdown. Inventory buildup ahead of Trump-era tariffs artificially skewed GDP figures. Net exports and reduced government spending are key contributors to the negative GDP number. Consumer spending was also shown to have slowed, adding to concerns about potential recession signals. A sharp drop in consumer spending could be a clear economic indicator of a downturn. Business investment surged after Trump's election due to economic optimism but has since stalled amid uncertainty Many business owners are holding back on investment due to a lack of visibility under the current administration. Shipping delays from China can take 30 days, meaning tariff effects won't be felt immediately but are now becoming visible. A drop in container orders from China suggests supply chain disruptions are already underway. The "bullwhip effect" explains how small supply chain changes can cause large swings in inventory and pricing. Warren Buffett is still sitting on significant cash, possibly anticipating better buying opportunities amid market volatility. A coming inventory crunch could cause inflation as demand outstrips constrained supply. Post-COVID rebounds in same-store sales distort trend lines and may create false signals. The official CPI of 21% over five years doesn't align with real-world price experiences, suggesting data manipulation. Government inflation numbers may be inaccurate or understated, leading to misguided investing decisions. Investors should rely on personal experience and intuition—the “bullshit detector”—instead of blindly trusting official data.   Today's Panelists: Kirk Chisholm | Innovative Wealth Douglas Heagren | ProCollege Planners Follow on Facebook: https://www.facebook.com/moneytreepodcast Follow LinkedIn: https://www.linkedin.com/showcase/money-tree-investing-podcast Follow on Twitter/X: https://x.com/MTIPodcast For more information, visit the show notes at https://moneytreepodcast.com/central-banks-are-hoarding-this-asset-711

Send us a textBetsy Corcoran and Dr. Jeremy Roschelle co-host the Future Fluent podcast, where they explore how learning is changing in the age of AI. Betsy is the cofounder of EdSurge and now leads Lede Labs, advising education leaders. Jeremy is a leading learning scientist and Executive Director of Learning Science Research at Digital Promise. Together, they bring decades of journalism and research experience to their shared mission: redefining literacy and learning in a world transformed by AI.

GPPR Podcast Editor Mitchell Zupko (MPP'25) chats with Devin Gerzof, the Executive Director of Executive Branch Relations and Federal Relations at the American Hospital Association. They discuss the No Surprises Act, site neutral payments, reimbursements, the 340B Program, and more.

SJ Show Notes:Please support Shannon's independent network with your donation HERE:https://www.paypal.com/donate/?hosted_button_id=MHSMPXEBSLVT6Support Our Sponsors:You can get 20% off your first order of Blackout Coffee! Just head to http://blackoutcoffee.com/joy and use code joy at checkout.The Satellite Phone Store has everything you need when the POWER goes OUT. Use the promo code JOY for 10% off your entire order TODAY! www.SAT123.com/JoyBe ready before you need it! Stock up now and protect your family. Go to https://www.allfamilypharmacy.com/JOY and use code JOY10 for 10% off your order.The 100% toxin free P600 sizzle set is 55% OFF for the SJ audience!! Go to https://www.chefsfoundry.com/joy today to claim the limited time discount!Get 45% OFF Native Path HYDRATE today! Special exclusive deal for the Joy audience only! Check it out HERE: www.nativepathhydrate.com/joyColonial Metals Group is the company Shannon trusts for all her metals purchases! Set up a SAFE & Secure IRA or 401k with a company who shares your values! Learn more HERE: https://colonialmetalsgroup.com/joyPlease consider Dom Pullano of PCM & Associates! He has been Shannon's advisor for over a decade and would love to help you grow!Call his toll free number today: 1-800-536-1368Or visit his website at https://www.pcmpullano.comTune in LIVE Today ——>Watch LIVE TODAY and follow the SJ Show on Rumble HERE: https://rumble.com/c/TheShannonJoyShowShannon's Top Headlines April 29, 2025:CLICK HERE To Stop The #DrDeath Bill In NYS: https://www.votervoice.net/AUTISMACTION/Campaigns/115959/Respond?unregistered=_ttc9anYD9aeEliyHNSITQDr. Bowden's TMB Hearing Recap: https://x.com/MstrKapln/status/1916987344709706166MUST Watch! Catherine Austin Fitts On Tucker Carlson: https://x.com/TuckerCarlson/status/1916900992299290637How A President Becomes A Dictator: https://www.stridentconservative.com/how-a-president-becomes-a-dictator-by-executive-orders/NRx: Technocracy's Underground Political System That Wants To Destroy Democracy: https://www.technocracy.news/nrx-technocracys-underground-political-system-wants-to-destroy-democracy/Five years post COVID and it seems nothing has changed.In fact, things are getting much worse.Despite a perceived ‘victory' for the medical freedom community with the Trump presidency, it seems that we are moving backwards and the transformation of our health system into a comprehensive, incentivized death system is accelerating despite the installation of Robert Kennedy Jr. as HHS Secretary.Consider the fact that yesterday in the supposed red state of Texas, the grotesque, 3 year persecution of Dr. Mary Talley Bowden continued as the Texas Medical Board conducted an absolutely absurd, 7 hour hearing in an attempt to convict Dr. Bowden for trying to save the life of a beloved father and sheriff during COVID, by treating him with ivermectin.“They are literally using old Twitter posts, comments, and replies as evidence to punish her. Freedom of speech is on trial in Texas, as is physicians' ability to practice ethical, Hippocratic, individualized care versus totalitarian protocols dictated for all.” She added, “The entire profession of medicine in Texas is on trial here, particularly the ability to care for patients using hard-earned wisdom, knowledge, and ethics.” ~Dr. Kris HeldOn the same day, legislators in New York moved to legalize doctor-assisted murder with a Mengelian new bill expanding the death powers of physicians.According to advocate John Gilmore: “Senate Bill S138 (Brad Hoylman-D), which would allow physicians to “assist” suicides … a great threat to disabled people, especially people impacted by severe developmental disabilities. This law would be the first, and most important step, to allow institutions to kill inconvenient people.”Today Dr. Clayton Baker joins us with his perspective as a physician who stood up to COVID atrocities in Rochester, NY and has joined the battle to save the practice of healing. Dr. Baker just released a new book entitled “The Medical Masquerade: A Physician Exposes the Deceptions of Covid” where he seeks to “understand how and why it all happened took him step by step, further and further, into the labyrinth of lies, corruption, and outright murderousness that lay behind the lockdowns, the assault on civil rights, the monumental suffering, and the millions of deaths of the Covid era.”See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Unlock the Power of Style: How Your Clothing Choices Influence Leadership Presence and Trust | Janice MeredithDiscover how your clothing choices influence leadership presence and trust in this transformative episode of The Leadership Launchpad Project! Join hosts Susan Hobson, Liane Wansbrough and Shelley West as they sit down with renowned fashion expert Janice Meredith to explore the hidden connection between personal style, confidence, and executive impact.

What happens when your recruitment business grows too fast?Sasza Bandiera shares hard-earned lessons from scaling after COVID, the hidden cost of lowering standards, and how she's rebuilding stronger.A candid conversation for founders navigating growth, culture, and getting back on track.Connect with Sasza here: https://www.linkedin.com/in/saszabandiera/-------------------------Watch the episode on YouTube: https://youtu.be/co-Ln3Oqut0-------------------------Sponsors - Claim your exclusive savings from our partners with the links below:Sourcewhale - Check Out Sourcewhale & Claim Your Exclusive Offer Here.Raise - Check Out Raise & Claim Your Exclusive Offer Here.-------------------------Extra Stuff:Learn more about our online skills development platform Hector here: https://bit.ly/47hsaxeJoin 4,000+ other recruiters levelling up their skills with our Limitless Learning Newsletter here: https://limitless-learning.thisishector.com/subscribe-------------------------Get in touch:Linkedin: https://www.linkedin.com/in/hishemazzouz/-------------------------

In his weekly clinical update, Dr. Griffin with Vincent Racaniello deplore the US's withdrawal from the global health community for pandemic preparedness i.e. the universal avian flu vaccine, and undermining the use of routine childhood vaccinations for pertussis and measles, RFK's autism registry, yellow fever outbreak in Colombia and world immunization week after discussing the squirrel as the reservoir host for mpox, before Dr. Griffin reviews recent statistics on RSV, influenza and SARS-CoV-2 infections the WasterwaterScan dashboard, how immunity elicited by the RSV vaccine wanes in 3 years, if Paxlovid reduces stroke, where to find PEMGARDA, provides information for Columbia University Irving Medical Center's long COVID treatment center, where to go for answers to your long COVID questions, if vaccination impacts long COVID and if long COVID were to become epidemic. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode The American Public's Disengagement With Highly Pathogenic Avian Influenza (HPAI): Considerations for Vaccination and Dietary Changes(American Public Health Association) New agreement geared toward universal avian flu vaccine (CIDRAP) Cambridge's DIOSynVax and Singapore's ACM Biolabs to advance pandemic-ready universal bird flu vaccine with international support (GlobeNewswire) Bird flu continues to spread among live poultry markets after shut down order  (CRAIN'S New York Business) Fire-footed rope squirrels (Funisciurus pyrropus) are a reservoir host of monkeypox virus (Orthopoxvirus monkeypox)(Research Square) It is a squirrel! An animal source of mpox emerges(Nature) Whooping cough spikes, especially among unvaccinated teens (NBC News) A February flu surge has arrived (NCB News) Pertussis Cases by Year (1922-2022)(CDC: Whooping cough (pertussis))) ‘Fighting to breathe': Whooping cough surges as vaccination rate falters (NBC News) CDC cancels measles help for Texas schools amid staff layoffs (HealthDay) Measles cases and outbreaks (CDC Rubeola) Measles in Texas…. (Texas Health and Human Services) Measles vaccine recommendations from NYP (jpg)  2025 Measles outbreak guidance (New Mexico Health) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Measles (CDC Measles (Rubeola)) Measles (CDC: Measles Rubeola) Adverse events associated with childhood vaccines: evidence bearing on causality (NLM) Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America) Deaths following vaccination: what does the evidence show (Vaccine) RFK Jr.'s autism registry plan (Axios) RFK Jr's autism study collecting Americans' private medical records (Guardian) The public's views on measles outbreaks and misinformation (KFF)  Colombia National Emergency: yellow fever cases (Gov.Co) World Immunization Week: polio eradiation?(GPEI) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) Respiratory virus activity levels (CDC Respiratory Illnesses) 200 children die from flu (CIDRAP) Weekly surveillance report: clift notes (CDC FluView) FDA-CDC-DOD: 2025-2046 influenza vaccine composition (FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Trial shows waning efficacy of RSV vaccine across 3 seasons in older adults(CIDRAP) Efficacy, safety, and immunogenicity of the AS01E-adjuvanted respiratory syncytial virus prefusion F protein vaccine (RSVPreF3 OA) (LANCET: Respiratory Medicine) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Infusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Long-term stroke and mortality risk reduction associated with acute-phase paxlovid use in mild-to-moderate COVID-19(Journal of Medical Virology) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) When your healthcare provider is infected/exposed with SARS-CoV-2 (CDC) Managing healthcare staffing shortages (CDC) Steroids, dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID The effect of COVID-19 vaccination on the risk of persistent post–COVID-19 condition (JID) ORCHESTRA Delphi consensus: diagnostic and therapeutic management of Post-COVID-19 condition in vulnerable populations (CMI Clinical Microbiology and Infection) Political ideology and trust in scientists in the USA(Nature Human Behavior) Leading long COVID researcher fears it could become a national epidemic (Spectrum News NY1) Center for post COVID care (Mt. Sinai) Reaching out to US house representative Letters read on TWiV 1212 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

On this episode of Leadership on the Links, we sit down with Jason Straka, a seasoned golf course architect with over 30 years of experience designing and renovating courses worldwide. Jason's background in agronomy, environmental design, and construction gives him a unique perspective on the evolution of golf course architecture. We discuss the post-COVID design trends reshaping the industry, from short courses and reversible layouts to an increasing emphasis on sustainability and environmental stewardship. Jason also shares insights into the collaborative process between architects, superintendents, and club members—highlighting what makes a project truly successful. If you're passionate about the future of golf course design, this episode is a must-listen! Key Takeaways

Cinq ans après la survenue de la pandémie qui a bouleversé le monde du travail, qu'en reste-t-il ? Dans « La Story », le podcast d'actualité des « Echos », Margaux Boulte et son invitée font le point.Retrouvez l'essentiel de l'actualité économique grâce à notre offre d'abonnement Access : abonnement.lesechos.fr/lastoryLa Story est un podcast des « Echos » présenté par Margaux Boulte. Cet épisode a été enregistré en avril 2025. Rédaction en chef : Clémence Lemaistre. Invitée : Noëmie Cicurel (directrice de la formation Europe chez Robert Half). Réalisation : Willy Ganne. Chargée de production et d'édition : Michèle Warnet. Musique : Théo Boulenger. Identité graphique : Upian. Photo : iStock. Sons : Le Nouvel Obs, Journal l'Humanité, Palmashow, LCI, TF1. Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

The invaluable expertise of classroom teachers is the foundation of effective civic education, as demonstrated by three veteran educators who share their experiences developing curriculum that truly engages students.• Teachers know their students better than anyone, allowing them to create curriculum that addresses knowledge gaps• Post-COVID classrooms present unique challenges that only current teachers fully understand• Teachers should not shy away from controversial topics but instead use primary sources to help students form opinions• Professional networks and connections significantly enhance teaching effectiveness• "Chunking" lessons into 12-15 minute segments keeps students engaged, especially in today's attention-challenged environment• Administrators must trust teachers' judgment and provide meaningful support• Teacher-developed curriculum is more practical and effective than lessons created by those distant from classrooms• Building mentor relationships is crucial for new teachers facing the challenges of the professionWant to expand your professional network? Reach out to Liz Evans at lizevans@asu.edu to connect with experienced educators who can support your civic education journey. The Arizona Constitution ProjectCheck Out Our Free Lessons on Arizona History and Government!Follow us on:TwitterLinked InInstagramFacebookYouTubeWebsiteInterested in a Master's Degree? Check out the School of Civic and Economic Leadership's Master's in Classical Liberal Education and Leadership

A Miami University researcher studied how the pandemic impacted school boards and their ability to serve their communities.

What is long COVID? What are the signs of long COVID? Does getting COVID multiple times increase long COVID risk? What long COVID treatments are available? Akiko Iwasaki, PhD, Sterling Professor of Immunobiology at Yale University, discusses new long COVID research, emerging treatments for long haul COVID, and the latest from the Yale Long COVID clinic. American Medical Association CXO Todd Unger hosts.

Episode 140: Grab the Ultimate Ad Script right HERE - https://join.digitaltrailblazer.com/ultimate-ad-scriptLive, in-person events, like masterminds and retreats, used to be a lot easier to be profitable with.Now, post-covid, it seems like getting attendees and running profitable events is much more difficult. Many industry leaders have even stopped doing live events because of their struggles with making them profitable.Yet, there are still others who are knocking it out of the park with their live events.In this episode, Shannon Jamail gives us the details about what the winners are doing that the losers are not and how to be profitable with live events in 2025 and beyond.About Shannon Jamail: Shannon is the founder and creator of the Mind & Body Complete Family of Companies which includes her retreat center, Retreat Ranch, outside of Austin Texas. She is a best-selling author, podcast host, retreat leader, therapist turned mentor, Yoga Teacher trainer and tequila connoisseur (not really but she does enjoy sipping on a good pour). Shannon has a passion and a mission to elevate individuals in mind & body in order to connect, grow & thrive through her online courses, books, programs & retreats.  She lives on her ranch with her family in the Hill Country of Texas.Check out Shannon's Courses & Training: http://mindbodycomplete.com/ - use code: TRAILBLAZER for 10% off any program or retreatConnect with Shannon: https://theretreatranch.com/ https://www.facebook.com/mindandbodycomplete/ https://www.instagram.com/mindbodycomplete/ https://www.facebook.com/retreatleadersplaybook https://www.instagram.com/retreatleadersplaybook/ https://www.instagram.com/retreat_ranch/ https://www.facebook.com/retreatranchGrab the Ultimate Ad Script right HERE - https://join.digitaltrailblazer.com/ultimate-ad-script✅ Connect With Us:Website - https://DigitalTrailblazer.comFacebook - https://www.facebook.com/digitaltrailblazerTikTok: https://www.tiktok.com/@digitaltrailblazerTwitter: https://twitter.com/DgtlTrailblazerInstagram: https://www.instagram.com/DigitalTrailblazer

Ever wondered what it takes to run Kentucky's FIRST no-kill animal rescue?

In his weekly clinical update, Dr. Griffin and Vincent Racaniello lament about the continuing measles outbreak, whether or not the measles outbreak was predicted, the FACTS about vaccination, high pathogenic influenza, H5N1 contaminated raw pet food, children's deaths, before Dr. Griffin reviews recent statistics on RSV, influenza and SARS-CoV-2 infections and vaccination schedules and the efficacy of Moderna's seasonal mRNA vaccine, societal burden of COVID-19 and influenza, the FDA missed deadline for approving Novovax COVID vaccine, the WasterwaterScan dashboard, where to find PEMGARDA, provides information for Columbia University Irving Medical Center's long COVID treatment center, where to go for answers to your long COVID questions, long COVID interventions, and Canada's long COVID dashboard. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode CDC buried a measles forecast that stressed the need for vaccinations….TRANSPARENCY? (Politico) Measles cases and outbreaks (CDC Rubeola) Measles 159 in Texas…. (Texas Health and Human Services) 2025 Measles outbreak guidance (New Mexico Health) Measles and rubella weekly monitoring report (Government of Canada) Enhanced epidemiological summary Measles in Ontario (Public Health Ontario) Measles and rubella weekly monitoring report (Government of Canada) Enhanced epidemiological summary Measles in Ontario (Public Health Ontario) Measles exposures in Ontario (Public Health Ontario) Measles vaccine recommendations from NYP (jpg) Get the FACTS about measles (NY State Department of Health) Measles (CDC Measles (Rubeola)) Measles vaccine (CDC Measles (Rubeola)) Presumptive evidence of measles immunity (CDC) Contraindications and precautions to measles vaccination (CDC) Measles (CDC Measles (Rubeola)) Raw cat food tests positive for H5N1 (CIDRAP) Influenza: Waste water scan for 11 pathogens WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) Respiratory virus activity levels (CDC Respiratory Illnesses) FDA-CDC-DOD: 2025-2046 influenza vaccine composition (FDA) RSV: Waste water scan for 11 pathogens (WastewaterSCan) US respiratory virus activity (CDC Respiratory Illnesses) RSV-Network (CDC Respiratory Syncytial virus Infection) Early impact of RSV vaccination in older adults in England (Lancet) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Evaluating the effectiveness of 2024-2025 seasonal mRNA-1273 vaccination against covid-19-associated hospitalizations and medically attended covid-19 among adults aged ≥ 18 years in the united states(medRxiv) Current Moderna vaccine 53% effective against COVID hospitalization?(CIDRAP) Preliminary estimates of COVID-19 burden for 2024-2025 (CDC COVID-19) Estimated range of annual burden of flu in the US from 2010 – 2024 (CDC-flu burden) US FDA missed the deadline for decision on Novavax's COVID-19 vaccine (Reuters) Interim clinical considerations for use of COVID-19 vaccines in the United States (CDC Vaccines & Immunizations) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Fusion center (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Metformin alleviates inflammatory response and severity rate of COVID-19 infection in elderly individuals(Scientific Reports) Drug interaction checker (University of Liverpool) Infectious Disease Society guidelines for treatment and management (ID Society) Cost-effectiveness analysis of nirmatrelvir/ritonavir for high-risk individuals with COVID-19….does this mean use the big button calculator? (OFID) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) When your healthcare provider is infected/exposed with SARS-CoV-2 (CDC Managing healthcare staffing shortages (CDC) Steroids, dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Reinfection with SARS-CoV-2 in the omicron era is associated with increased risk of post-acute sequelae of SARS-CoV-2  infection: a recover-EHR cohort study(medRxiv) CAN-PCC RecMap, your one-stop shop for recommendations about Post COVID-19 Condition (Long COVID) (Canadian Guidelines for post COVID-19 condition) Letters read on TWiV 1206 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv Content in this podcast should not be construed as medical advice.

As we reflect on the fifth anniversary of COVID this month, Lynn and Ed discuss its impact on kids' social interactions. Have adults stopped modeling and teaching social norms? Are we allowing our children to avoid social, in-person experiences and then calling it anxiety? Do we need to do better? WE'VE MADE PLAYLISTS OF OUR EPISODES TO HELP YOU FIND RESOURCES ON SPECIFIC TOPICS. Here is our first: Parents of Anxious Kids, Start Here For those brand new to the podcast, we suggest starting with this playlist featuring Lynn Lyons and the 7-part anxiety disruptor series as well as a 3-part series on the skills most helpful in managing anxious kids: flexibility, problem solving, and autonomy. Consult our Spotify profile for the most up-to-date selection.   WIN A COPY OF THE ANXIETY AUDIT COURSE! We will select two listeners who complete our listener survey. We hope it is you!   FOLLOW US Join the Facebook group to get news on the upcoming courses for parents, teens, and kids. Follow Flusterclux on Facebook and Instagram. Follow Lynn Lyons on Twitter and Youtube. VISIT OUR SPONSORS FOR SPECIAL OFFERS JUST FOR YOU: Go to Quince.com/fluster for 365-day returns, plus free shipping on your order!   Right now, our listeners get an additional 15% off any annual membership at MASTER CLASS.com/FLUSTER.   Go to PrettyLitter.com/flusterclux to save twenty percent on your FIRST order and get a free cat toy.   Visit revivalrugs.com and use code FLUSTER20 for 20% off your first order.   For a limited time, get Headspace FREE for 60 days. Go to Headspace.com/FLUSTER.   Head to lumen.me/FLUSTERCLUX for 20% off your purchase. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Today's Flash Back Friday episode is from #660 that originally aired on Oct. 23, 2023. Join us as Alex Jarbo, the visionary founder and CEO of Sargon Investments, takes us on a journey into the world of short-term rental resort development. With an MBA in real estate development, a distinguished history as a Marine, and a prominent presence in the real estate investing community, Alex shares his expertise in a special episode. Discover how he masterfully manages his current and upcoming luxury short-term vacation rentals, including an exciting treehouse project. Dive into the world of short-term rentals with Alex Jarbo on the YouTube channel "Alex Builds," and gain insights from the industry's best.   Quote:  “I hate it when I talk to someone and I'm like, “Oh what business are you in or what type of real estate they're in and they say, “I'm in AirBnBs.” That's the wrong answer. What I say is I'm in vacation rentals, short term rentals, or what I started saying in the last six months is, “I'm in hospitality.”  “Every single one of your guests is an influencer, because they have their own following.“   Highlights:  7:50: Post-COVID, what is the revenue like in short term rentals?  12:30: From an owner's perspective  19:40: Treehouse community project  24:00: Amenities people expect  27:30: How to navigate uncertainties   Connect with Alex: alexjarbo.com  Openatlas.investments  https://www.youtube.com/@AlexBuilds1    Recommended Resources: Accredited Investors, you're invited to Join the Cashflow Investor Club to learn how you can partner with Kevin Bupp on current and upcoming opportunities to create passive cash flow and build wealth. Join the Club! If you're a high net worth investor with capital to deploy in the next 12 months and you want to build passive income and wealth with a trusted partner, go to InvestWithKB.com for opportunities to invest in real estate projects alongside Kevin and his team.  Looking for the ultimate guide to passive investing? Grab a copy of my latest book, The Cash Flow Investor at KevinBupp.com.  Tap into a wealth of free information on Commercial Real Estate Investing by listening to past podcast episodes at KevinBupp.com/Podcast.

StoneOnAir with Bryan Stone PODCAST SHARE - local perspective on stories, headlines, music, entertainment, more! Find all things Bryan Stone at: https://stoneonair.com/ or www.noogapodcasts.com - We love having it on The Nooga Podcast Network! THIS EPISODE - Big local music weekend, Nightfall Concert Series line-up, #cha news/notes, 5 years since COVID & who gets to decide what the generations are? === THANK YOU TO OUR SPONSORS: Vascular Institute of Chattanooga: https://www.vascularinstituteofchattanooga.com/ The Barn Nursery: https://www.barnnursery.com/ Optimize U Chattanooga: https://optimizeunow.com/chattanooga/ Guardian Investment Advisors: https://giaplantoday.com/ Alchemy Medspa and Wellness Center: http://www.alchemychattanooga.com/ Chattanooga Concrete: www.chattanoogaconcreteco.com Roofingco.com: www.roofingco.com ALL THINGS JEFF STYLES: www.thejeffstyles.com PART OF THE NOOGA PODCAST NETWORK: www.noogapodcasts.com Please consider leaving us a review on Apple and giving us a share to your friends! This podcast is powered by ZenCast.fm

SmartStop Self Storage's CEO, H. Michael Schwartz, discusses why now was the time to IPO. He discusses the difference between American and Canadian markets, with Canadians moving less than Americans – which he says makes the business stronger. He talks about their storage offerings and how they're bringing automation to the process post-Covid, as well as how they manage demand.======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

It's been more than five years since the World Health Organization identified the virus known as COVID-19 as a pandemic. But there are still many unknowns about Post-COVID, or Long COVID. Here's how the longer-lasting illness looks in the state.

Die Symptome, von denen manche Menschen nach einer Corona-Impfung berichten, ähneln denen von Post-Covid. Doch weil die Fallzahlen so niedrig sind, ist ein Zusammenhang zwischen Impfung und dem sogenannten PostVac-Syndrom schwer zu beweisen. Von Joachim Budde Quelle: https://www.deutschlandfunk.de/gibt-es-postvac-auf-der-suche-nach-beweisen-fuer-corona-impfschaeden-100.html / Bitte abonniert den Original-Podcastfeed: https://www.deutschlandfunk.de/wissenschaft-im-brennpunkt-102.xml

In this episode, Chris Davey discusses his journey in e-commerce, the growth of his networking event at the Canton Fair, and insights into navigating the complexities of sourcing from China. We share our experiences about the safety concerns in China, travel challenges, and the importance of thorough research when attending trade shows.    We also talk about the networking opportunities going to China provides for Amazon sellers. We delve into the intricacies of product sourcing and development in the e-commerce space, particularly focusing on the advantages of Chinese manufacturing. We discuss strategies for identifying niche markets, the importance of building strong relationships with suppliers, and the rapid product development process that allows sellers to capitalize on emerging trends. The conversation also highlights the significance of differentiation in a competitive market and the benefits of being a first mover. The Big Takeaway Chris's product sourcing strategy involves developing accessories for popular products. The Canton Fair is divided into three phases, each focusing on different product categories. Networking is a key benefit of attending the Canton Fair. Post-COVID, there are fewer American attendees at the Canton Fair. Visa regulations for entering China can be complex and vary by nationality. Chris emphasizes how important of visiting suppliers' factories in China. Attendees should plan for at least 10 days to fully experience the Canton Fair. Designing accessories around popular products is effective. Predictive keyword popularity can lead to successful products. Niche markets can provide significant opportunities. Building relationships with factories is crucial for success. Rapid product development is key to staying competitive. Differentiation is essential in a crowded market. First-mover advantage can lead to increased sales. Networking events like FBA for You foster community among sellers. Timestamps 00:00 - Introduction to FBA4U and Chris Davey 01:57 - Chris's Journey to E-commerce and Canton Fair 06:02 - Growth of FBA4U and Networking Opportunities 09:56 - Safety and Visa Concerns in China 15:54 - Canton Fair Insights and Supplier Strategies 23:32 - The Speed of Chinese Manufacturing 24:15 - Innovative Product Sourcing Strategies 27:15 - Niche Markets and Competitive Advantages 30:02 - Building Relationships with Factories 32:10 - Rapid Product Development Process 35:13 - The Importance of CAD in Product Design 39:11 - Differentiation in a Competitive Market 43:24 - Leveraging First-Mover Advantage 44:55 - Managing Minimum Order Quantities 46:51 - Building Strong Supplier Relationships 50:18 - FBA for You: Networking and Community Thanks for listening! Until next time, happy selling!

#594: Ever wonder if you could afford to travel for months at a time? According to Nomadic Matt, who's visited more than 100 countries over the last 19 years, you can see the world on just $75 a day. That's about $27,375 per year, less than many people's current cost of living. Matt Kepnes, better known as Nomadic Matt, joins us to challenge common assumptions about travel costs. He explains that long-term travel can actually be cheaper than staying home. When you're traveling, you shed many regular expenses that eat into your budget back home, like car payments, home insurance, and utility bills. The key is to "travel like you live," as Nomadic Matt puts it. This means using public transportation instead of taxis, shopping at local markets, and seeking out free activities — just like you might do in your hometown. It's not about staying at five-star resorts, but experiencing destinations authentically while keeping costs reasonable. Nomadic Matt also breaks down several travel myths. The old advice about booking flights on Tuesdays? Outdated in today's algorithmic pricing world. Using incognito mode to get better flight prices? No evidence supports this idea. He does confirm that booking round-trip flights often costs less than one-way tickets, even if you don't use the return portion. For those interested in credit card points, Nomadic Matt recommends choosing cards based on your specific travel goals rather than chasing the most popular options. Consider which airlines you use most and what perks you'll actually take advantage of. The pandemic has transformed travel in significant ways. While prices have increased and some budget travel services have disappeared, new opportunities have emerged — especially for remote workers who can now take advantage of digital nomad visas to live abroad while maintaining their income. Whether you're planning a two-week vacation or dreaming of becoming location-independent, Nomadic Matt's practical advice shows how international travel is more accessible than you might have thought. Timestamps: Note: Timestamps will vary on individual listening devices based on dynamic advertising run times. The provided timestamps are approximate and may be several minutes off due to changing ad lengths. (0:00) Intro to Nomadic Matt and $75/day budget (1:00) Modern hostels aren't grungy anymore (3:00) Origins of the $75/day travel budget (5:00) "Travel like you live" approach saves money (8:50) Mix accommodations based on trip needs (9:40) Choose travel cards matching your specific goals (16:40) Use points before devaluation happens (20:00) Best booking times for flights (37:00) Social media's impact on global travel (42:00) Overcoming language barriers easily (48:30) Post-COVID travel costs and changes (56:20) Remote work visas for long-term travelers (1:02:40) Why travel costs less than staying home (1:05:50) How location independence evolved from unusual to mainstream Learn more about your ad choices. Visit podcastchoices.com/adchoices

Adam Guild is the co-founder and CEO at Owner, an online food ordering system for independent restaurants. Within a year, Owner went from being about to run out of money to having hundreds of customers. Last year, they raised a $33M Series B. Adam's entrepreneurial journey began as a teenager when he built a successful Minecraft server, which led him to drop out of high school to become a founder. His passion for helping small businesses was sparked by his mom's struggles running a dog grooming shop, which led him to launch the early iteration of Owner. -- In today's episode, we discuss: How working with a small business kickstarted Owner Adam's unusual outbound strategy Why the pandemic accelerated Owner's success How Owner's pivot led to “hyperbolic” product-market fit The two qualities Adam looks for in new hires -- Referenced: Alex Bard: https://www.linkedin.com/in/alexbard/ Dean Bloembergen: https://www.linkedin.com/in/deanbloembergen/ Guisados: https://www.guisados.la/ HubSpot: https://www.hubspot.com/ Jack Altman: https://www.linkedin.com/in/jackealtman/ Kimbal Musk: https://www.linkedin.com/in/kimbalmusk/ Modern Restaurant Management: https://modernrestaurantmanagement.com/ Naval Ravikant: https://www.linkedin.com/in/navalr/ Neil Patel: https://www.linkedin.com/in/neilkpatel/ Peter Thiel: https://www.linkedin.com/in/peterthiel/ P.F. Chang's: https://www.pfchangs.com/ Sean Rad: https://www.linkedin.com/in/seanrad/ Thiel Fellowship: https://thielfellowship.org/ Tim Ferriss: https://www.linkedin.com/in/timferriss/ Y Combinator: https://www.ycombinator.com/ -- Where to find Adam: LinkedIn: https://www.linkedin.com/in/adamharrisonguild/ -- Where to find Brett: LinkedIn: https://www.linkedin.com/in/brett-berson-9986094/ Twitter/X: https://twitter.com/brettberson Where to find First Round Capital: Website: https://firstround.com/ First Round Review: https://review.firstround.com/ Twitter/X: https://twitter.com/firstround YouTube: https://www.youtube.com/@FirstRoundCapital This podcast on all platforms: https://review.firstround.com/podcast -- Timestamps: (00:00) Intro (01:29) Adam's first business (04:15) The transition from Minecraft to Owner (05:58) The dark side of the gaming industry (14:20 Adam's scrappy strategy to landing his first customers (16:52) The COVID pivot (21:31) The quest to find product-market fit (30:53) What actually worked to get new customers (36:03) Inside Owner's explosive growth (46:41) How Owner secured its crucial first round of funding (53:34) The bet on going multi-product (64:28) What Adam wishes he knew at 17 (76:22) Sales-led vs. product-led growth

Hey, Heal Squad! Maria is back with Part 2 of her amazing conversation with Jenny McCarthy! We know her as an actress, New York Times bestselling author, host of The Masked Singer (Wednesdays on FOX!), and founder of the vegan, cruelty-free beauty brand, Formless Beauty—but today, Jenny is getting real about her incredible healing journey. From battling celiac disease and Hashimoto's to uncovering shocking truths about oral health, Jenny shares the alternative approaches she used to heal her body and why she said buh-bye to one of the most popular diets in America. And just when you think she's said it all—Jenny drops a jaw-dropping revelation about a groundbreaking therapy she discovered to heal post-COVID vaccine injuries. Maria was left speechless! Let's just say everything Jenny has learned on her health and wellness journey has led her to create Formless Beauty, her brand that takes clean beauty to the next level. Get ready for an eye-opening, empowering, and inspiring conversation. We hope you enjoy it!  HEALERS & HEAL LINERS:  Keep an Open Mind To Healing: Jenny urges people to do their own research, explore anecdotal evidence, and keep an open mind to emerging healing methods. She revealed groundbreaking alternative therapies using low-dose nicotine patches to help with her post-COVID vaccine injuries, chronic fatigue, and even type 1 diabetes.  EWG Standards For Clean Beauty: Jenny founded Formless Beauty to create truly clean beauty products after learning that many brands falsely claim to be "clean." She works with the Environmental Working Group (EWG) to ensure her products meet the highest safety standards, avoiding harmful chemicals commonly found in makeup.  The Link Between Oral Health & Chronic Illness: Jenny discovered that hidden infections from root canals and wisdom tooth extractions were contributing to her health issues. She encourages people to visit biological dentists to check for underlying infections that may impact overall wellness. -- HEAL SQUAD SOCIALS IG: https://www.instagram.com/healsquad/ TikTok: https://www.tiktok.com/@healsquadxmaria HEAL SQUAD RESOURCES: Heal Squad Website: https://www.healsquad.com/ Maria Menounos Website: https://www.mariamenounos.com My Curated Macy's Page: Shop My Macy's Storefront AquaTru: https://aquatruwater.com/  code: HEALSQUAD Prenuvo: Prenuvo.com/MARIA for $300 off Sleep Number: https://www.sleepnumber.com/ EPISODE RESOURCES: Follow Jenny on Instagram & TikTok: The Masked Singer Airs Wednesdays on Fox Formless Beauty EWG Root Cause Documentary ABOUT MARIA MENOUNOS: Emmy Award-winning journalist, TV personality, actress, 2x NYT best-selling author, former pro-wrestler and brain tumor survivor, Maria Menounos' passion is to see others heal and to get better in all areas of life. ABOUT HEAL SQUAD x MARIA MENOUNOS: A daily digital talk-show that brings you the world's leading healers, experts, and celebrities to share groundbreaking secrets and tips to getting better in all areas of life. DISCLAIMER: This Podcast and all related content (published or distributed by or on behalf of Maria Menounos or http://Mariamenounos.com and http://healsquad.com) is for informational purposes only and may include information that is general in nature and that is not specific to you. Any information or opinions provided by guest experts or hosts featured within website or on Company's Podcast are their own; not those of Maria Menounos or the Company. Accordingly, Maria Menounos and the Company cannot be responsible for any results or consequences or actions you may take based on such information or opinions. This podcast is presented for exploratory purposes only. Published content is not intended to be used for preventing, diagnosing, or treating a specific illness. If you have, or suspect you may have, a health-care emergency, please contact a qualified health care professional for treatment.

America Out Loud PULSE with Dr. Mary Talley Bowden – Dr. Kimberly Biss, a Tampa OB-GYN, raises concerns about COVID-19 vaccine safety in pregnancy. Citing rising miscarriage rates and suppressed data, she challenges public health narratives. Backed by clinical experience and research, her findings call for deeper scrutiny into vaccine effects on reproductive health and maternal outcomes.

America Out Loud PULSE with Dr. Mary Talley Bowden – Dr. Kimberly Biss, a Tampa OB-GYN, raises concerns about COVID-19 vaccine safety in pregnancy. Citing rising miscarriage rates and suppressed data, she challenges public health narratives. Backed by clinical experience and research, her findings call for deeper scrutiny into vaccine effects on reproductive health and maternal outcomes.

You rely on wireless connectivity, we all do… and having a good wireless system can have a big impact on the success of your business. As companies strive for greater flexibility, efficiency, and connectivity, Wireless First is emerging as a game-changer. Post Covid, we're seeing employees want more dynamic and collaborative work environments, and teams need to be able to move freely and adapt to those changing spaces quickly. We'll discuss the benefits of wifi 7 and why building a private 5G wireless network can be a great way to increase bandwidth. This episode is hosted by Helen Gidney, Softcat's head of Architecture as we talk tech in simple jargon free language. Helen is joined by Simon Wilson, CTO For UK and Ireland at HPE and Tom Rowley, Networking and Connectivity Chief Technologist at Softcat. This episode was produced by The Podcast Coach. Hosted on Acast. See acast.com/privacy for more information.

Guest: Tony Stillinger   Guest Bio: I have been in the seal and gasket business for 37 years. I started off in production and quality, moving into sales in 1997. I quickly learned that to be successful in a sales role you needed to be self-motivated, competitive, reliable, and a great listener (2 ears > 1 mouth). I have had the privilege of working for a multi-billion-dollar giant in the industry to a small distributorship. I have found that sales leadership gives me great satisfaction. I love coaching and talking sales strategy with my team. I get more enjoyment from their success than my own. I guess you could say I view my success is tied to their success. My current position with ESP has been very satisfying because I was tasked with finding acquisitions, building a sales team, and guiding the team toward acquiring new business. I told one of my direct reports this morning that I don't see retirement in my future because I love what I do and the company I work for.   Key Points:  Background, Journey to Sales, and Path to Engineer Seal Products: · Tony started in production and quality at Southern Rubber in Greensboro, NC, with a family connection and gained valuable product knowledge. · Attended college at night while working, with the goal of transitioning into sales; found success despite being an introvert by focusing on listening to customers and solving their problems. · Moved to Engineer Seal Products after helping them explore acquisitions in the Southeast; later, ESP acquired Southern Rubber, Tony's former employer.   Cold Calling and Prospecting: · Cold calling is a primary strategy for new business acquisition, particularly in the Southeast region, where ESP had limited presence before the speaker joined. · Post-COVID hybrid work schedules have made cold calling more challenging, but it has still led to valuable conversations and new accounts. · Tony views cold calling as less common today, which gives their team an advantage in reaching decision-makers.   Sales Team Development and Coaching: · Building a sales team from scratch required careful coaching and mentoring, particularly in managing the frustration of cold calling. · The sales process can be slow and requires persistence. Tony compares sales to a baseball player, where even a 30-40% success rate is considered good. · Coaching involves encouraging perseverance, trying different strategies, and using personal stories to motivate the team.   Hiring and Training Salespeople: · When hiring, Tony looks for candidates with a "hunter mentality" and technical knowledge of the industry, understanding that the sales cycle is long-term. · The interview process involves assessing candidates' daily routines, sales plans, and role-playing cold calls. · Tony values networking to find potential candidates and looks for people willing to hunt for new business rather than manage existing accounts.   Mistakes in Hiring: · Tony shared a past hiring mistake involving a candidate with the right skills but who had personal issues that impacted their work. · The lesson learned was to inquire more about personal hobbies and interests during the hiring process, which may reveal potential red flags.   Overall Philosophy: · Tony emphasizes the importance of caring for employees and helping them succeed, which adds to the satisfaction of leadership. · Even though firing employees can be painful, it is sometimes necessary for the benefit of the company. · Tony's competitive nature and enjoyment of challenges drive their success in building teams and acquiring new business.   Guest Links: https://www.linkedin.com/in/tonystillingermbasalesgrowth/     About Salesology®: Conversations with Sales Leaders Download your free gift, The Salesology® Vault. The vault is packed full of free gifts from sales leaders, sales experts, marketing gurus and revenue generation experts. Download your free gift, 81 Tools to Grow Your Sales & Your Business Faster, More Easily & More Profitably. Save hours of work tracking down the right prospecting and sales resources and/or digital tools that every business owner and salesperson needs. If you are a business owner or sales manager with an underperforming sales team, let's talk. Click here to schedule a time. Please, subscribe to Salesology®: Conversations with Sales Leaders so that you don't miss a single episode, and while you're at it, won't you take a moment to write a short review and rate our show? It would be greatly appreciated! To learn more about our previous guests, listen to past episodes, and get to know your host, go to https://podcast.gosalesology.com/ and connect on LinkedIn and follow us on Facebook and Instagram and check out our website at https://gosalesology.com/.

Die Symptome, von denen manche Menschen nach einer Corona-Impfung berichten, ähneln denen von Post-Covid. Doch weil die Fallzahlen so niedrig sind, ist ein Zusammenhang zwischen Impfung und dem sogenannten PostVac-Syndrom schwer zu beweisen. Budde, Joachim www.deutschlandfunk.de, Wissenschaft im Brennpunkt

Leue, Vivien www.deutschlandfunk.de, Deutschland heute

Genentech VP, CMO Erica Taylor joins The Current Podcast to share her unique journey from immunology to biotech marketing, and the evolving role of biotech brands in mainstream media.  Episode TranscriptPlease note, this transcript  may contain minor inconsistencies compared to the episode audio.Kat Vesce (00:00):I'm Kat Vesce. And I'm Ilyse Liffreing and welcome to this edition of The Current Podcast. In honor of International Women's Day and Women's Month, we're spotlighting trailblazing women in marketing at this year's South by Southwest.Ilyse Liffreing (00:16):For this episode, we're excited to be joined by Erica Taylor, vice president and chief marketing Officer at Genentech, a company at the forefront of biotech innovation for over 40 years.Kat Vesce (00:28):Erica has a unique background transitioning from a PhD in immunology and a product development into the world of marketing, bringing a scientific perspective to how Genentech connects with global healthcare providers and patients.Ilyse Liffreing (00:41):We'll dive into how that background informs her approach to marketing, the game changing campaign she's led, and how the biotech industry is evolving to embrace more creative, emotionally driven storytelling.Kat Vesce (00:54):Plus Erica will share her perspective on how women in STEM can break barriers and what the future of healthcare marketing holds. Let's get started.Ilyse Liffreing (01:01):So Erica, thanks for being here at South by Southwest. Thanks for having me. Of course. So you have a unique background for a CMO growing part of your career on the product development side of biotech. After earning your PhD from Stanford Medical School, what drew you to the marketing side of biotech and why don't we see more medical students transition into heading up marketing departments?Erica Taylor (01:25):Yeah, I sometimes think that I have the habit of just showing up in places I'm not supposed to be, and so I certainly didn't go into my studies in immunology with the idea that I was going to end up in marketing. I would've never have thought that that would be the case. It really sort of became apparent to me that I was very much interested in the intersection of business and science when I was nearing the end of my graduate program, but I wasn't really sure how to do that or how to get there. So I explored a lot and I often share when I do development conversations with folks in the industry that I've probably not gotten more jobs than I've gotten in my life trying to figure out how to be in these other spaces. But for me, the journey really started in consulting.(02:07):I was in management consulting for biotech and pharma industry, and that is what led me to Genentech. And at my career there I have had roles in analytics and in sales, and it was probably my time in sales that really got me interested in marketing. And so I was able to sort of land a role in marketing and to do so at a company that innovates on science. I think they were able to sort of see, okay, she maybe doesn't have a background in marketing, but she understands the science, she understands how to communicate it and what actually moves markets when you're in the sales field.Ilyse Liffreing (02:38):How has that background informed your approach as a CMO? Why is that scientific medical knowledge and maybe even sales knowledge so valuable?Erica Taylor (02:48):Yeah, I think one of the things that was a bit of an aha for me in my sales role was I'll say one of the most professionally transformative experiences I had, which is code for saying it was the hardest thing I've ever done. And you learn a lot about what actually motivates people in the decisions that they make. And marketing is really focused on influencing a decision that people make and you realize even though I have a background in science and people very much need to understand why they're making the decision they're making. If you're a provider making a prescribing decision or a patient choosing between options for medicines available to you, you need to understand the why of that. But really there has to be some kind of emotional pull there. And I was really fascinated with that because I sort of come from a very cerebral training of like, well, we've got this data and here are the patients for which benefit the most, and so therefore this is the natural conclusion of the decision you would make. In fact, it's far more complex than that and it's that complexity of human behavior that I got really interested in as I grew in the marketing organization. So I try to bring both the left and right brain such as it were to that thinking.Kat Vesce (03:53):As the best marketers do. We ask everyone this question, I want to go a little bit deeper. Is there a specific moment that changed the game for you as a marketer? Tell us your most defining career moment or pivot to date and what the obstacles were there.Erica Taylor (04:10):Yeah, I could probably name a few. I get the most depth in moments and insights when I actually get to interact with patients and with providers and sort of understand deeply their experiences. And one of the ahas that I got actually both in my sales and then later in my marketing role is that yes, Genentech, you guys have been trailblazing and biotech and you have been innovating, but the data is so complex even though I'm trained in this field with the patient loads that I see every day, I don't have time and you guys don't make it simple for us. And so the aha there is like, okay, then marketing campaigns have to really focus on taking very complex science, which I feel fortunate to understand, but boil it down to something that's very simple, that's very memorable. And the same for patients. Very often when I'm in conversations with providers, I have the patient in mind when I'm thinking about how I would want this medicine explained to me, and that is how I explain it to the provider thinking maybe if a couple of my phrasing or words sort of land, well then that's what gets repeated to the patient so that they understand the choices that they have before them.Kat Vesce (05:17):I love that. And as a biotech company now over 40 years old, how would you say your approach to campaign strategy differs from typical healthcare campaigns?Erica Taylor (05:25):Yeah, well for one,Kat Vesce (05:26):A little bit of that patient in mind.Erica Taylor (05:28):Yeah, the patient for sure in mind. And one of the things that I'm very happy to spearhead as the chief marketing officer is really thinking about how do we make that more and more personal? It's not the patient, it is the patient that may be a single parent that lives 45 minutes from their local healthcare system. How do I speak to that patient just as much as I speak to the patient that has a high powered career and really doesn't have the time to focus on themselves and needs something to be quick and convenient? And so really the opportunity before us is to figure out how to become more nuanced, relevant and personalized when we tell the stories of our medicines. What I love about Genentech and our ability to do that is we've always been focused on two things, patience and science. And as long as we keep those two centered in everything that we do, I think we're able to kind of meet that mark.(06:14):Maybe the other thing I'll add, because the idea of speaking in personalized ways is not new. It's not rocket science, it's not even the more complex things that we do, but the technology and the capabilities that exist maybe outside of healthcare are now being applied in our space. And so very excited about what things like generative AI can do for us and really being able to personalize our stories around our medicines and our development. But at scale, we market over 40 medicines, and so it's great to do this in one or two places, but imagine doing that across the full breadth of our portfolio.Kat Vesce (06:47):And I imagine that 40 medications or medicines times however many profiles fit the many faces of patients.Erica Taylor (06:57):Exactly.Kat Vesce (06:58):Yeah, you really need some automation there.Erica Taylor (07:00):Absolutely. The scale of the problem is impossible, and unless I'm getting sort of a complete blank check to build all the resources that I need, we've got to find ways to be more efficient with that.Ilyse Liffreing (07:09):So that has really got me thinking because as much as the customer is number one and everything, but you also have to speak to the provider and they're the ones who are going to be really selling your medicine to the patient themselves. How do you solve, I guess, for your need to resonate with both the customer provider and then who would you consider highest priority in those campaigns?Erica Taylor (07:34):No, it's a really, really great question. One of the things that I love about the healthcare space is that your decision maker and your end user are almost never the same person. And that's not totally unique. It's uncommon. But you could imagine parents buying baby formula are also decision makers, but generally not. And users, unless you were like me and got desperate and ran out of half and half and put baby formula in, coffee works great. Extra nutrients. Exactly. Yeah, life hack. So it's not totally unique, but you have to kind of speak to two audiences. So because of the breadth of our portfolio, we really do think about this disease state by disease state. So there are some disease states where really the provider is the driving decision maker. Examples of this can be if you're having a stroke and you're in the hospital, you're probably not deciding between which medications are right for now, you're really driven by the provider's decision maker.(08:31):You can think about that in some of our later line cancer portfolios. When you're in your past, your first two lines of treatment, you're really going to be relying on your provider to understand what are the next, so in those cases, we tend to focus more on the provider and the prescribing decision maker. There are other parts of our portfolio where it's really very much patient driven. We have a medicine that treats food allergy, and that really then tends to involve in some cases, adolescents, their parents. And so we really need to elevate their voices when we're thinking about how we make sure they have the right information. So it really can span the gamut, and it's about taking a specific view of that particular disease state and how decision-making is made.Ilyse Liffreing (09:09):That's amazing. Now the biotech category is not known for being exactly sexy when it comes to creative marketing. It's bogged down with side effects and similar storylines usually. How are you guys moving the needle in terms of creating those powerful maybe storytelling campaigns?Erica Taylor (09:30):Yeah, I mean, we are a regulated industry and I'll state first. It's actually really important that we give that information. Any medicine that anyone is going to take, you have to weigh the benefits and the risks, and it is on us to communicate that fairly. And so I very much stand behind that. As a scientist, we really have to do that, but that can also make it really hard to know what's what we're trying to do this. So for me, I always try to root in the emotion and what I tell my teams all the time at the end of everything we do is someone who is sick and scared and how do we really tap into that? What do they need in that moment of diagnosis? What do they need in that moment when they're a week out from treatment and they're not really sure if what they're experiencing is normal?(10:14):Really kind of capturing those moments along the patient's journey. And similarly for the provider's journey, if I were to be oversimplified providers saying 15, 20 patients a day, how do we find ways to make their challenging lives as easy as possible, as simple as possible? And so we kind of think of that almost in two tracks. Some of the best creative that I see really speaks to that emotion. We did a campaign in our ophthalmology franchise last year called A Beautiful Site, which really chronicles a parent watching their child go through the education and then that parent one day becoming a patient. And it's really a motive. We actually don't talk a ton about the medicine itself, but more the experience of what it's like when you're struggling with your eyesight and it's gotten a lot of traction just by speaking to that lived experience.Kat Vesce (11:03):We're going to shift the conversation and zoom out a little bit.Erica Taylor (11:05):Okay.Kat Vesce (11:05):Though biotech is not new by any means, the category was catapulted into the spotlight in mainstream media during the height of COVID-19 something very intimately a thing or two. Yes. Yeah. Gilead at the time, you saw this firsthand with your previous role. And tell us a little bit about that experience. What do you think has changed for the industry as a whole since then?Erica Taylor (11:27):Oh wow. So many things. I had so many reactions kind of experiencing as we all did. The sort of the Covid Ovid 19 crisis, the first among them is that science really became front and center. And as a scientist, I get excited, finally, we're getting the credit we deserve, but so much about it was what I understand is science. Science is slow and painstaking. It's a step forward, it's a step to the right, it's a step back. It's two steps forward. That is how science happens. The lay public for the most part just sees it at the end. And so you get to tell this story, but that's not actually how it went down. Think about your vaccines for things like polio. We weren't following the day to day of that. We just had it. And we go, great. That's wonderful science. So when looking through the vaccine development for Covid, we're kind of watching day by day, is it six feet?(12:17):What kind of mask? How do I do this? And so we got, I think people lost trust in science and that really was heartbreaking because that's actually how it is. And for me it's the resilience of the people that continue to pursue when you get up and the thing you thought was going to work didn't work today, and you get up tomorrow and go do it. And we were able to break through in that way. That's the one thing on the science side, on the marketing side, we now know names of biotech companies. No one generally does know that I get true. My branded medication, I get this branded, that branded medication. Now the names of the companies that produced the vaccines, you would go in and say, I want the Moderna one or the Pfizer one. That has never really happened before in our industry.(13:03):And we've had to go from being a sort of what I'll call a house of brands, the branded medication, to really thinking about, well, what is the worth in branding the house, the Genentechs of the world? We're actively thinking about how we do that, especially as we come to our 50th anniversary as a company next year. So I know there's a lot of activity and thinking, how do we strategically do this that is authentic to who we are as an organization and elevates all of the work that we do, all of the scientists that pursue day in and day out, all of the patients that we've been able to help improve the lives of.Kat Vesce (13:39):So in a world that we've been talking about has changed so much since Covid. Absolutely. People also expect more from companies than ever before. How do you align your corporate positioning with Genentech, with your creative output?Erica Taylor (13:51):Yeah. I think to me this is about relevance and authenticity. I think there's so much content in your life in and out of healthcare to consume, and I think people are far more discerning of what feels authentic to them, what feels true, what feels pandered to right today is International Women's Day. There's lots of celebrations around Women's Day. Not everyone has been consistent about really centering women and thinking about what are the things that women could benefit from and could use, I think, and the women walking around here today, they know the difference. And so I think for us, the onus is being true to who we are, being authentic, really, and as relevant as we can. And I think about that just sort of from the broader Genentech, but also how do we think about this product by product? What is the authentic experiences and where do we show up really matters? One of the things that I tell my teams all the time, I'm like, we'd say the word patient. They are people, which sounds obvious, but you can easily lose sight of the fact that the fact that someone is a patient is probably in the bottom five of the top 100 things they like about their life. So you want to be there when needed and the hell out of their lives when not. Right. And so how do we thread that line appropriately,Ilyse Liffreing (15:13):Right? Yeah,Erica Taylor (15:14):It's hard. It's hard. It's hard.Ilyse Liffreing (15:16):You could argue it's harder than your average CPG brandErica Taylor (15:19):ForIlyse Liffreing (15:19):Instance.Erica Taylor (15:20):Absolutely.Ilyse Liffreing (15:21):Absolutely.Erica Taylor (15:22):So it keeps it interesting for sureIlyse Liffreing (15:23):Yeah. Now, I know we kind of talked about this a little bit, but I wanted to zoom out here a little bit because of this trend, it seems like it's a trend anyway, and I'm curious what you think, but during the Super Bowl, there were stronger examples of creative lead pharma and biotech ads competing against the typical ads you would see during the Super Bowl usually. What do you think about this? Is that where we're moving as an industry?Erica Taylor (15:51):I think it's interesting. I feel like I'm a student of commercials. I actually personally love football, so I consume every second of the Super Bowl bowls for the game and then the ads that show. I think it's interesting and I think it's a space worth exploring as an industry. And I think we've seen, there's a Pfizer ad that was released this year. I think they did one last year as well. I think we're still trying to figure out how to land the mark. And Super Bowl is an interesting venue to do that. Most people don't want to see a drug commercial. They're eating nachos, they're watching a game, they're maybe cheering on a team, they're waiting for the halftime show, whatever. But how do you land in a space that is supposed to be celebratory in light with something that's relevant and important? I think it's worth exploring personally. I'm sort of like, let's see where there might be a relevant kind of meeting of the moment. And it might be specific to just that year, right? Or just this particular thing that we have in our portfolio that's innovative that we want to make sure people know about.(16:54):I don't know that I'd paint a brush and do it everywhere for all things personally, a hundredKat Vesce (16:58):Percent. ButErica Taylor (16:59):I'm sure there's probably other marketers on this listening here that'll say, no, you should be pushing. And I'm curious, sort of very curious about where this could go and interested to see,Ilyse Liffreing (17:10):Since we're at South by Southwest and this is International Women's Day, I'd love to get your take on some of these female focused questions. Sure. So first of all, what inspired you to pursue a career in marketing and how has your journey been as a woman in the industry? I know with your strong STEM background especially, do you feel like there's still a much needed boost in how women pursue stem?Erica Taylor (17:34):Well, I am particularly passionate about STEM fields and as a self-proclaimed and bonafide nerd, I think the more in which ways in which we can celebrate that the better. I think it is interesting. We've seen increasing percentages of women pursuing STEM careers, which I applaud. It's not even the painted, I think more in medicine and healthcare related fields, I think there's still more gains to be had in fields like engineering and computer science. And one of the things that are very critical if we want to truly unlock things like artificial intelligence, I think there's more to do there. But I feel very much the, I feel like I'm coming behind women that have gone before and have really blazed trails, and I feel the same responsibility to make sure that whatever trail someone believes I've blazed or not is easier for whoever comes behind me. And I feel a deep obligation that I spend a good amount of my time mentoring and developing everyone, not just women, but folks that are interested in, as I call it, being in places you're not supposed to be. I think it just makes for a an interesting career path and journey. And I don't know what I'll do in the future. I still dunno what I want to do when I grow up. I'm having a great time now. And so I look to mentors that help see, oh, okay, that's how you did that.Kat Vesce (18:59):Can we better support women in leadership roles? You mentioned mentorship. What are some other ways you're leaning into that?Erica Taylor (19:06):Yeah, I think it can come up in both direct ways, like mentorship. I think those programs benefit everyone. And both I learned from them and I learn a lot about some of the challenges that people face in their careers now. I think there's subtle ways. One of, I think the most powerful things that we can do is as leaders show up honestly and authentically and not be afraid of showing moments of vulnerability. And I think it humanizes you. I had an experience last year where my husband got very, very ill and I needed to have a pretty major surgery. He's doing great now. But sort of living through that and thinking about how do I do the job? I've asked, I've been asked to do, but show up authentically with my team and let them know, Hey, I've got kind of a lot going on at home right now and I don't even know that I navigated that line well. But more recently actually got up on stage in front of my full organization and kind of shared the story. And I did it in the context of marketing and what it meant to have healthcare providers sort give me exactly what I need in the moment to help support him through this.Kat Vesce (20:22):What a full circle moment.Erica Taylor (20:24):It was somewhat of a spontaneous decision, but I think as certainly women leaders as leaders, your podcasters don't know this, but I'm a woman of color, so a lot of things that are not typical about where I show up in spaces. And the more that I can make it that I'm still human, I'm still me, and I go through life the same way you do, you never know what people are walking around with kind of position. I think that helps invite others to say, okay, maybe I didn't get a PhD. Maybe I don't have these things, but I am as human as she is and maybe I can make it there too. I think there's value in that, even though I was literally shaking in my boots to tell that story to one stage, that's a hard thing to do. And fighting to keep my composure and be as authentic as I could. Well,Kat Vesce (21:13):That's the most humanErica Taylor (21:14):Response ever. Yeah.Kat Vesce (21:15):So inspiring. What advice would you give to the next generation of marketing leaders, including we talked about not just young women, but everyone looking to grow into that leadership role?Erica Taylor (21:29):Yeah, I usually give, and there's a couple schools of thought on this, so this is sort of Erica's school of thought on this, right? I think that you have to strike this balance between having depth of knowledge but getting breadth of experience. And it's a really hard one to thread, especially if you're doing something you love. You just want to do more and more and more and more. And there may be great growth paths to be had in that. But a lot of the advice that I give to folks, it's like every time you think about pursuing another role, I am going to apply for this role. It's a promotion, it's a lateral, it think two moves ahead. Does it unlock more options for you? And be very aware, my more senior leaders, I'm like, you have to understand you're at a point in your seniority where making lateral moves gets harder.(22:12):And so you want to make them in your earlier points in your career when you can. Because one, there's just more of those roles. I'm a vice president, there's not a lot of us at Genentech. And so if I want to move laterally, I have fewer options. I have to be that much more thoughtful about it. But I feel like I come at this with the space of a more breadth of experience, but you still got to know the job. So you kind of have to navigate this sort of, as I call it, the difference between scuba and snorkel. If you can scuba dive and go deep, understand that that has ramifications for your career development. If you only snorkel, also ramifications for your career development. And then the other piece of advice I give folks is try not to plan more than a couple of years ahead because 10 years from now, you're going to do a job that doesn't exist today.(22:59):So I'm first CMO, so I couldn't have won this job. It didn't exist until three years ago, right? Plan for a couple of years at a time. And if you're weighing a couple of options that are otherwise equal to you go with the team you'd rather have more fun with, go with the team. You want to come hang out in Austin, Texas with, right? And you're never going to go wrong. Working on teams that you enjoy with each other. We have a really great and strong culture at Genentech, and I'm always like, if you see a leader you want to go work with, find a way to get on that person's team. So those are usually the kinds of advice I give to everyone. And then maybe the other, and this is more, I'm of a certain age wouldn'tKat Vesce (23:41):Know it. PodcastersErica Taylor (23:43):Of a certain age worry a lot less, and someone gave me this advice, what am I going to do? How am I going to get that job? Blah, blah, blah. You've got to work a long time. Most if you're lucky, and many people do, and so worry a lot less about what's going to happen in a decade, worry a lot less about that person that's your peer that just got that promotion and they're going to go farther than you. Career path is their own and everything happens kind of exactly as it should. And so I try really hard to, especially for folks that I get the sort of fresh from business school and they're like, I've got to be CEO in five years. And I'm like, I don't dunno. Let's worry a little less about the timing and worry much more about the kinds of experiences you get to have along the way, what you get to learn and who you get to meet.Kat Vesce (24:37):Well,Erica Taylor (24:37):Erica, thank youKat Vesce (24:38):So much and thanks for your vulnerability and sharing those tidbits and stories. I so appreciate this time. I know we're both leaving really inspired soErica Taylor (24:46):Much. Thank you. I'm so happy to do this. I appreciate the invite. I hope it's helpful for your listeners. Yeah, no, it great. I'm sure it will be. Thank you so much. Thanks.Kat Vesce (24:55):Wow. I am blown away. I am walking away from that conversation with Erica Taylor. So inspired. I don't know about you.Ilyse Liffreing (25:02):Oh my gosh, yes. I love how vulnerable she was about talking about her husband, and not only to, I mean us, but to her whole company. And it takes a very brave and smart woman to be able to be open like that.Kat Vesce (25:17):And also what a full circle moment. I mean to be the CMO of a company that is marketing, I think she said 40 different medications, and then to be on the receiving end of that and navigating as your own family is going through the fear and intensity of recovering from an ailment.Ilyse Liffreing (25:40):As she said, everybody has their own stuff they're going through.Kat Vesce (25:43):Yeah. Yeah. That was really inspiring. I also just loved how she went into the tension that she faces as a marketer, which I can't think of any other category that has this same predicament of wanting to stay relevant and be top of mind for the inpatient or the provider, but also not wanting to be there all the time, and to be able to dip in and out when needed. Because ultimately her end goal she was saying was to keep people healthy. And so I think that's a really refreshing take, especially hearing it from a biotech company like Genentech, that you could hear horror stories about companies being incentivized to keep people sick. And I just loved that as a marketer. She's thinking through it from a place of just being authentic to getting people healthyIlyse Liffreing (26:35):Completely. And she also mentioned in a world like Post Covid, everybody now has their eyes on those companies, which is huge because pre covid, nobody knew what shots you were getting from whom. And now it's like, what shot did you get? The Pfizer or the Moderna.Kat Vesce (26:55):Yeah. And there was even some kind of ranking around them at one point. Yeah, totally. So yeah. Yeah, that's really interesting how biotech and pharma are now getting into the brand marketing side of the house. And I liked her answer that she's trepidatious about how and when to deploy that. So overall, just super inspiring conversation. I'm walking away just beaming talking to all these amazing women. That's wonderful. And that's it for this edition of the current podcast. Be sure to tune in this whole month as we release all the recordings from South by Southwest. See you next time.

Medicaid is a program jointly funded by the federal and state governments. It provides health care coverage to nearly 80 million people, primarily those with low incomes, people who are living with disabilities or are in long-term care. On this episode we discussed the nuts and bolts of how Medicaid is financed and how states are handling some new challenges in the post-pandemic world. The pandemic affected both who Medicaid covered and the share paid by the federal and state governments.  In the first segment, NCSL's Kathryn Costanza was joined by Akeiisa Coleman from the Commonwealth Fund to break down the details of how the program is funded, including how the federal-state share is determined for each state. They also discussed the key drivers of cost in the Medicaid system. On the second segment, guests Neda Jasemi from the National Association of Medicaid Directors, and Robin Rudowitz from KFF talk about what they are hearing from Medicaid officials around the country. They discussed how the post-COVID unwinding of patients who had remained on the rolls during the pandemic had significant effects on the program. They also discussed steps states are taking to try to ensure access for Medicaid patients and how states are preparing for any changes in the program at the federal level. ResourcesCommonwealth Fund/MedicaidHealth Costs, Coverage and Delivery State Legislation Database, NCSLHow We Pay for MedicaidKFF/Medicaid“Medicaid Financing 101,” NCSL“Medicaid Toolkit,” NCSLNational Association of Medicaid Directors“Results from an Annual Medicaid Budget Survey for State Fiscal Years 2024 and 2025,” KFF“State Legislatures Address Medicaid Coverage and Payments in the 2024 Legislative Session,” NCSL“State Tax Actions: 2024,” NCSL“Top five Medicaid budget pressures for fiscal year 2025,” NAMD

Suzanne O'Sullivan is a neurologist who sees many patients with psychosomatic disorders. Their symptoms may be psychological in origin, but their pain is real and physical — and the way we practice medicine, she argues, is making those and other health problems worse. SOURCES:Suzanne O'Sullivan, neurologist and author of The Age of Diagnosis How Our Obsession with Medical Labels Is Making Us Sicker. RESOURCES:The Age of Diagnosis: How Our Obsession with Medical Labels Is Making Us Sicker, by Suzanne O'Sullivan (2025)."Associations of Depression, Anxiety, Worry, Perceived Stress, and Loneliness Prior to Infection With Risk of Post-COVID-19 Conditions," by Siwen Wang, Luwei Quan, Jorge Chavarro, Natalie Slopen, Laura Kubzansky, Karestan Koenen, Jae Hee Kang, Marc G. Weisskopf, Westyn Branch-Elliman, and Andrea Roberts (JAMA Psychiatry, 2022)."How beliefs about coronavirus disease (COVID) influence COVID-like symptoms? – A longitudinal study." by Liron Rozenkrantz, Tobias Kube, Michael H Bernstein, and John D.E. Gabrieli (Health Psychology, 2022)."Risk factors for worsening of somatic symptom burden in a prospective cohort during the COVID-19 pandemic," by Petra Engelmann, Bernd Löwe, Thomas Theo Brehm, Angelika Weigel, Felix Ullrich, Marylyn Addo, Julian Schulze Zur Wiesch, Ansgar Lohse, and Anne Toussaint (Frontier Psychology, 2022).The Sleeping Beauties: And Other Stories of Mystery Illness, by Suzanne O'Sullivan (2021).Brainstorm: Detective Stories from the World of Neurology, by Suzanne O'Sullivan (2018)."The Trauma of Facing Deportation," by Rachel Aviv (The New Yorker, 2017).It's All in Your Head: True Stories of Imaginary Illness, by Suzanne O'Sullivan (2015).The Body Keeps the Score: Brain, Mind, and Body in the Healing of Trauma, by Bessel van der Kolk (2014)."Explaining the Rise in Youth Suicide," by David Cutler, Edward Glaeser,and Karen Norberg (National Bureau of Economic Research, 2001). EXTRAS:Counted Out, documentary (2024)."Bringing Data to Life," by People I (Mostly) Admire (2023)."Adding Ten Healthy Years to Your Life," by People I (Mostly) Admire (2023)."America's Math Curriculum Doesn't Add Up," by Freakonomics Radio (2019).Race to Nowhere, documentary (2010).Data Science for Everyone.

Adam Maguire, from the RTÉ Business Desk

What stuck with us post Covid?   To advertise on our podcast, please reach out to sales@advertisecast.com or visit https://www.advertisecast.com/TheJeffWardShow

Willis Lease Finance Corporation's (WLFC) Austin Willis joins the Schwab Network to discuss the company's record-breaking year. With record revenues and profits, Willis attributes the success to a combination of factors, including the return of travel after COVID, the maintenance cycle of jet engines, and supply chain issues. He also touches on the impact of tariffs, inflation, and competition in the industry, and shares the company's strategy for continued growth and reinvestment in the business.======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/About Schwab Network - https://schwabnetwork.com/about

This week we take a look back at the past five years of Chandler's time in New York City—post-COVID edition. From surviving lockdown to navigating the chaos of a city that never sleeps (but definitely naps), we're cracking jokes, sharing stories, and asking: Was That In Good Taste?

On today's episode of the Smart Franchising Podcast, we sit down with Kathryn Chayka, the powerhouse who built massive success in franchise turnarounds, taking 12 struggling Wendy's locations and making a multi-million dollar success story. Fresh out of college, Kathryn took over a territory of underperforming Wendy's stores in Quebec and added over $1M in new revenue per location. She's proving that smart strategy, strong leadership, and local marketing can drive explosive franchise growth. Kathryn shares the secrets behind her success, including:- How she transformed struggling stores into high-revenue locations- The power of empowering leadership and supportive teams- Her community-first marketing strategies that boost both sales & loyalty- Post-COVID operational shifts that improved efficiency and profitability- Why learning from top-performing franchisees is key to long-term success “Delivering value doesn't mean sacrificing quality. Customers want great deals on quality products—when they feel they're getting value, sales follow.” Whether you're a franchisee, franchisor, or an entrepreneur looking to scale, this episode is packed with game-changing insights from someone who's built massive success in franchise turnarounds.

Send us a textShort Summary: Insider's look at the COVID-19 pandemic response from a seasoned epidemiologist, unraveling myths and lessons with straightforward science.About the guest: Martin Kulldorff, PhD is an epidemiologist and biostatistician with decades of experience in infectious disease monitoring and vaccine safety. He was formerly a professor at Harvard Medical School. Note: Podcast episodes are fully available to paid subscribers on the M&M Substack. Partial versions are available elsewhere. Full transcript and other information on Substack.Episode Summary: Dr. Martin Kulldorff discusses the COVID pandemic response, reflecting on the controversial Great Barrington Declaration, which opposed lockdowns in favor of protecting the vulnerable. They explore the virus's fatality rates, asymptomatic spread, and vaccine efficacy, contrasting textbook epidemiology with real-world decisions. He critiques institutional failures, like the CDC's misleading claims. He shares optimism for future pandemics with better leadership and public awareness.Key Takeaways:Lockdowns ignored basic public health principles, causing collateral damage like missed cancer screenings, while Sweden's focused protection approach led to lower excess mortality.Early data showed COVID's risk was 1000x higher for older people, yet lockdowns didn't prioritize them, unlike textbook strategies.Asymptomatic spread made containment impossible, unlike Ebola, where isolation works due to clear symptoms.Natural immunity was downplayed despite 2500 years of evidence, leading to wasted vaccines on those already immune.CDC falsely claimed vaccines stopped transmission, eroding trust when people got sick anyway, fueling vaccine skepticism.mRNA vaccine boosters lack proper trials, and their long-term effects need rigorous study, not assumptions.Kulldorff's new Journal of the Academy of Public Health pushes open peer review to rebuild trust in science.Related episode:M&M #100: Infectious Disease, Epidemiology, Pandemics, Health Policy, COVID, Politicization Support the showAll episodes, show notes, transcripts, etc. at the M&M Substack Affiliates: Lumen device to optimize your metabolism for weight loss or athletic performance. Use code MIND for 10% off. Readwise: Organize and share what you read. Athletic Greens: Comprehensive & convenient daily nutrition. Free 1-year supply of vitamin D with purchase. KetoCitra—Ketone body BHB + potassium, calcium & magnesium, formulated with kidney health in mind. Use code MIND20 for 20% off any subscription. MASA Chips—delicious tortilla chips made from organic corn and grass-fed beef tallow. No seed oils or artificial ingredients. Use code MIND for 20% off. For all the ways you can support my efforts

Dr. Sharon Hodde Miller leads Bright City Church in Durham, NC with her husband, Ike. She also has a PhD on women and calling, and is the author of several books, including her most recent one, The Cost of Control. We talk a lot about pastoral ministry, church planting, and how to cultivate resilience in ministry. Register for the Exiles and Babylon conference: theologyintheraw.com -- If you've enjoyed this content, please subscribe to my channel! Support Theology in the Raw through Patreon: https://www.patreon.com/theologyintheraw Or you can support me directly through Venmo: @Preston-Sprinkle-1 Visit my personal website: https://www.prestonsprinkle.com For questions about faith, sexuality & gender: https://www.centerforfaith.com Learn more about your ad choices. Visit megaphone.fm/adchoices